These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19219906)

  • 21. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of attack frequency in migraine treatment.
    Maas HJ; Snelder N; Danhof M; Della Pasqua O
    Cephalalgia; 2008 Aug; 28(8):847-55. PubMed ID: 18540870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations.
    Tarín C; Teufel E; Picó J; Bondia J; Pfleiderer HJ
    IEEE Trans Biomed Eng; 2005 Dec; 52(12):1994-2005. PubMed ID: 16366223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KINFIT: a non linear least-squares computer program for the estimation of pharmacokinetic parameters after intravenous administration.
    Kaltenbach ML; Vistelle R
    Anticancer Res; 1994; 14(6A):2375-7. PubMed ID: 7825975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing departure from dose linearity under a repeated measures incomplete block design.
    Cheng B; Chow SC
    Pharm Stat; 2011; 10(4):357-62. PubMed ID: 21104786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data.
    Allignol A; Schumacher M; Beyersmann J
    Biom J; 2010 Feb; 52(1):126-37. PubMed ID: 20140901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the drug transport in the anterior segment of the eye.
    Avtar R; Tandon D
    Eur J Pharm Sci; 2008 Oct; 35(3):175-82. PubMed ID: 18662774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model-free evaluation and mean-time concept in pharmacokinetics.
    Brockmeier D
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):593-602. PubMed ID: 3784698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.
    Gibson CR; Bergman A; Lu P; Kesisoglou F; Denney WS; Mulrooney E
    Xenobiotica; 2009 Sep; 39(9):637-48. PubMed ID: 19480559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better design of drug-eluting stents using computer modeling.
    Park K
    J Control Release; 2009 Jan; 133(1):1. PubMed ID: 19038297
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
    Dokoumetzidis A; Kalantzi L; Fotaki N
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The method of statistical moments and the integral model-independent parameters of pharmacokinetics].
    Piotrovskiĭ VK
    Farmakol Toksikol; 1986; 49(5):118-27. PubMed ID: 3533616
    [No Abstract]   [Full Text] [Related]  

  • 35. [1D-and 3D- computer simulation for experimental planning and interpretation of pharmacokinetic studies in the inner ear after local drug delivery].
    Plontke S; Siedow N; Hahn H; Wegener R; Zenner HP; Salt AN
    ALTEX; 2004; 21 Suppl 3():77-85. PubMed ID: 15057412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control engineering for planning drug therapy.
    Deutsch T; Sali A
    Acta Physiol Hung; 1993; 81(1):3-11. PubMed ID: 8178653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Note in statistical treatment of medical and pharmaceutical data.
    Kawase M; Konishi H; Yagi K; Nishikiori R; Takagi T
    J Biosci Bioeng; 2005 Jul; 100(1):116-8. PubMed ID: 16233861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The time course of drug effects.
    Al-Sallami HS; Pavan Kumar VV; Landersdorfer CB; Bulitta JB; Duffull SB
    Pharm Stat; 2009; 8(3):176-85. PubMed ID: 19626596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.
    Chiou WL; Huang SM; Huang YC
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):1-4. PubMed ID: 7364527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
    Zeng YL; Akkermans AA; Breimer DD
    Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.